Tagged with Researc

Brazil Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research throughout Latin America on neglected diseases.   This agreement establishes an exchange of know-how that will provide progress in public health policies in Brazil Patrice Matchaba, global head of corporate responsibility, Novartis…

Czech Republic The Czech Republic is aiming to carve out a space for itself among Europe’s most innovative countries by 2030 as part of the ‘Innovation Strategy of the Czech Republic 2019–2030.’ While a number of promising steps have already been taken, it is far too soon to tell whether the Czechs…

Hungary Investments in research and development are on the rise in Hungary, backed up by government initiatives, but the country needs a more unified effort between the public and private sectors to truly deliver on its innovation potential.   On the Up Globally, R&D spending has been on a sturdy upward…

China John Moller, CEO; and Yooni Kim, executive director of Asia operations, for Novotech, share the competitive positioning of Novotech as a full-service CRO for biotech companies interested in the Asia-Pacific region; the solutions and services they offer, including their clinical development consultancy, ‘BioDesk’; as well as the exciting opportunities they…

Sweden InDex Pharmaceuticals is a Swedish biopharma company developing drugs that could help patients suffering from ulcerative colitis, an inflammatory bowel disease. CEO Peter Zerhouni gives an overview of the company’s journey, including the recent phase IIb results of their lead asset, cobitolimod, and the future strategy to bring the product…

Sweden The 2019 Nobel Prize in Physiology or Medicine was awarded to three scientists for their discovery of how cells sense and adapt to oxygen availability. Since the establishment of the Nobel Assembly in 1901 at the Karolinska Institute in Sweden, 219 researchers have been awarded the Nobel Prize in Physiology…

China Dr Irwin Wang, CEO of Reistone Biopharma, shares her motivations behind the establishment of the company, their extremely productive collaboration with Jiangsu Hengrui (China’s largest pharma company by market capitalization), and their exciting international clinical development strategy for their three assets.   I realized that if I wanted to establish…

USA BioNJ’s president and CEO Debbie Hart reflects on the association’s mission of creating a robust and engaging life sciences ecosystem in New Jersey. Hart also outlines how BioNJ is hoping to continue to grow the region’s reputation as a hub that stands out for its level of expertise, favourable geographic…

Sweden Anders Wesslau, the newly appointed general manager for Merck KGaA’s business units in Sweden, underlines how Merck’s healthcare business is a well-integrated player in the innovative Swedish life sciences ecosystem, illustrates the company’s innovation partnerships with key research institutions, and how Merck is developing new technologies and solutions with key…

Sweden IQVIA is a leading global provider of information, innovative technology solutions and contract research services for the healthcare industry. Stefan Ohlsson, general manager at IQVIA Nordics, discusses how Sweden’s unique quality registries can be further improved, the company’s ability to help clients at any stage of development, and how IQVIA…

Clinical Trials Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in the country since 2015 has some stakeholders concerned about the future of Hungary as a regional clinical trials hub.   …

Sweden Swedish Labtech is an industry organization for companies involved in laboratory activities. Chairman Peter Simonsbacka discusses the challenges facing the life science industry, the opportunity to bring back the strong clinical trials tradition in the country and the unique Swedish collaborative ecosystem.   Sweden has a very open environment when…